Voyager Therapeutics (VYGR) Tax Provisions (2016 - 2026)

Voyager Therapeutics has disclosed Tax Provisions across 7 years of filings, most recently posting $14000.0 for Q1 2026.

• Tax Provisions for Q1 2026 came in at $14000.0, down 62.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $121000.0 (down 82.41% YoY), and the FY2025 annual result was $144000.0, down 78.35% from the prior year.
• Tax Provisions came in at $14000.0 for Q1 2026 at Voyager Therapeutics, up from $9000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $822000.0 in Q4 2023 to a low of -$177000.0 in Q3 2023.
• The 4-year median for Tax Provisions is $37000.0 (2025), against an average of $171615.4.
• Peak annual rise in Tax Provisions reached 164.29% in 2025, while the deepest fall reached 98.46% in 2025.
• Voyager Therapeutics' Tax Provisions stood at $822000.0 in 2023, then declined by 28.95% to $584000.0 in 2024, then slumped by 98.46% to $9000.0 in 2025, then soared by 55.56% to $14000.0 in 2026.
• The last three Tax Provisions figures came in at $14000.0 (Q1 2026), $9000.0 (Q4 2025), and $83000.0 (Q3 2025), per Business Quant data.